Ensayo clínico NCT05132075 · Non-Small Cell Lung Cancer

Ensayo clínico NCT05132075 (fase III) figura como «activo (sin reclutamiento)» en ClinicalTrials.gov.

Patología: Non-Small Cell Lung Cancer · Intervenciones registradas: JDQ443, docetaxel · Fechas registradas (fuente): 2022-06-15, 2026-09-03, 2021-11-24, 2026-09-25.

Resumen del estudio (fuente: ClinicalTrials.gov, texto original en inglés):

This is a phase III randomized open label study designed to compare JDQ443 as monotherapy to docetaxel in participants with advanced non-small cell lung cancer (NSCLC) harboring a KRAS G12C mutation who have been previously treated with a platinum-based chemotherapy and immune checkpoint inhibitor therapy either in sequence or in combination.

Fuente: https://clinicaltrials.gov/study/NCT05132075